Dany Anglicheau
Prof Dany Anglicheau is an expert in Surgery at Hôpital Necker-Enfants Malades (France). As of October 2026, ScienceLeadR ranks Dany Anglicheau in the top 1% of experts worldwide for Kidney Transplantation. Dany Anglicheau has authored 414 publications, the most recent in 2026, and is an investigator in 19 clinical trials, 6 of them ongoing. SLR score: 1,546 (community average: 125). How the SLR is computed.
LeadR Profile
Surgery
Subspecialties: Transplantation - Nephrology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2001 - 2026
Number : 414
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Non-HLA antibodies worsen the histological phenotype and prognosis of antibody mediated rejection in kidney allografts. PMID 42498055 — kidney diseases, antibodies, phenotype, kidney, graft survival, biopsy, transplants, wounds and injuries, allografts, prognosis | Kidney Int | 2026 | 0 |
| The Polycystic Kidney as a Staphylococcal Reservoir. PMID 42686020 — kidney diseases, kidney | Kidney Int | 2026 | 0 |
| Urinary CXCL9 Across the Spectrum of Kidney Allograft Inflammation. PMID 42621113 — phenotype, kidney, biopsy, transplants, allografts | Kidney Int Rep | 2026 | 0 |
| Anti-CD38/Anti-CD20 Rescue Therapy for Posttransplant Recurrent FSGS. PMID 42571438 — cells, antibodies, plasma cells, blood component removal, kidney, glomerulosclerosis, focal segmental, transplants, therapeutics, kidney transplantation, b-lymphocytes, plasma | Kidney Int Rep | 2026 | 1 |
| Severe Undernutrition Predicts Adverse Outcomes in Transplant Norovirus Infection. PMID 42500309 — mortality, malnutrition, caliciviridae infections, kidney, diagnosis, transplants, diarrhea, infections, norovirus | Kidney Int Rep | 2026 | 0 |
Clinical Studies 19
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 7
Ongoing Clinical Trials
6 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Screening for subclinical antibody mediated rejection and efficacy of belatacept in the context of de novo donor specific antibody after kidney transplantation BEL AMR 2024-516527-13-00 — kidney, biopsy, kidney transplantation, transplantation | Phase 3/Phase 4 | Not yet recruiting | 2026 |
| Letermovir valganciclovir combination versus valganciclovir monotherapy for treatment of cytomegalovirus (CMV) infections in kidney transplant recipients 2023-506216-40-00 — cytomegalovirus infections, kidney, cytomegalovirus, transplants, therapeutics, infections, valganciclovir | Phase 3 | Recruiting | 2024 |
| CMV associated Immunomodulation in Renal Transplant Patients NCT06976008 — immunomodulation, phlebotomy, blood, cytomegalovirus infections, kidney, cytomegalovirus, viremia, immunity, transplants, kidney transplantation, organ transplantation, transplantation, infections | N/A | Not yet recruiting | 2025 |
| EVEROLD LONG TERM FOLLOW UP NCT06504225 — kidney, everolimus, transplants, kidney transplantation, transplantation | N/A | Recruiting | 2024 |
| Detection of Circulating Kidney DNA in Kidney Transplant Patients Facing an Episode of Graft Rejection NCT06351488 — graft rejection, psychology, blood, classification, kidney, biopsy, rejection, psychology, diagnosis, transplants, dna | N/A | Recruiting | 2024 |
LeadR Networks
Main global connection map